SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 144 | 1 | 148 | +5 |
| Shares | 55.3M | 1.61K | 63.3M | +7.99M (+14.5%) |
| Value | $1.36B | $40.0K | $1.80B | +$436.4M (+32.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (20)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Nomura Holdings Inc | 506,772 | $13.4M |
| Cormorant Asset Management, LP | 475,000 | $11.7M |
| AXA S.A. | 107,022 | $2.63M |
| TCW Group Inc | 74,671 | $1.84M |
| Walleye Capital LLC | 65,949 | $1.62M |
| Tudor Investment Corp Et Al | 41,184 | $1.01M |
| Bank of Montreal | 30,948 | $785.0K |
| Jane Street Group, LLC | 22,196 | $547.0K |
| Man Group plc | – | $472.0K |
| ETF Managers Group, LLC | 15,681 | $400.0K |
| CSS LLC | 12,200 | $300.0K |
| Virtu Financial LLC | 10,329 | $254.0K |
| SG Americas Securities, LLC | 7,335 | $181.0K |
| Simplex Trading, LLC | 5,531 | $136.0K |
| Cutler Group LP | 3,300 | $81.0K |
| Group One Trading, L.P. | 3,014 | $74.0K |
| Caption Management, LLC | 1,993 | $49.0K |
| International Biotechnology Trust PLC | 401 | $16.3K |
| Captrust Financial Advisors | 119 | $3.00K |
| Moisand Fitzgerald Tamayo, LLC | 12 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 1,615 | $40.0K |